Generating monoclonal cell lines, monoclonal antibodies, and labeled monoclonal antibodies against PTH-IA, POP 5/26/21 - 5/25/2022.

Ended Awarded Last action

Contract number
75N95021F00001
Awardee
Awarding agency
Obligated
$40,945

Award facts

Opportunity
  • 75N95021R00032 Solicitation number
Contract value 100% obligated
$40,945.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition Basic Research
Pricing
Firm Fixed Price
Place of performance
Columbia, MD 21045, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $3,342
Original award $37,603

Quick answers

Who was awarded contract 75N95021F00001?

75N95021F00001 was awarded to A&G Pharmaceutical, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 26, 2021.

How much is contract 75N95021F00001 worth?

The government has obligated $40,945 on 75N95021F00001.

Which agency awarded contract 75N95021F00001?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95021F00001 an order under another contract?

Yes. 75N95021F00001 is a delivery order under 75N95018D00010, an indefinite delivery contract.

Was contract 75N95021F00001 competed?

The extent of competition for 75N95021F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award